Skip to main content
. Author manuscript; available in PMC: 2020 Jul 27.
Published in final edited form as: J Med Econ. 2019 Mar 25;22(7):662–670. doi: 10.1080/13696998.2019.1591424

Table 2.

HCRU per patient during the entire follow-up by maximum LOT received.

HCRU All Patients
(N = 1,873)
No Chemotherapy
(n = 1,035)
LOT1 Only
(n = 514)
LOT1 & LOT2 Only
(n = 209)
LOT3+
(nN = 115)
P-value,
LOT3+ vs No Chemotherapy
Bladder biopsy
N (%) of patients 1,751 (93.5) 920 (88.9) 510 (99.2) 206 (98.6) 115 (100.0) < .001
 Mean (SD) 2.85 (2.36) 2.22 (1.84) 3.41 (2.62) 3.83 (2.72) 4.18 (2.83) < .001
 Median (IQR) 2 (1–4) 2 (1–3) 3 (2–4) 3 (2–4) 3 (2–5)
Cystoscopy
N (%) of patients 1,306 (69.7) 606 (58.6) 426 (82.9) 175 (83.7) 99 (86.1) < .001
 Mean (SD) 1.61 (2.11) 1.11 (1.71) 2.03 (2.18) 2.42 (2.72) 2.77 (2.51) < .001
 Median (IQR) 1 (0–2) 1 (0–1) 1.50 (1–2) 2 (1–3) 2 (1–4)
Cystectomy
N (%) of patients 606 (32.4) 248 (24.0) 223 (43.4) 90 (43.1) 45 (39.1) < .001
 Mean (SD) 0.33 (0.49) 0.25 (0.45) 0.45 (0.52) 0.44 (0.53) 0.42 (0.55) < .001
 Median (IQR) 0 (0–1) 0 (0–0) 0 (0–1) 0 (0–1) 0 (0–1)
Radiation
N (%) of patients 612 (32.7) 231 (22.3) 198 (38.5%) 110 (52.6%) 73 (63.5%) < .001
 Mean (SD) 2.16 (3.99) 1.20 (2.89) 2.57 (4.15) 4.17 (5.13) 5.39 (5.75) < .001
 Median (IQR) 0 (0–3) 0 (0–0) 0 (0–4) 2 (0–8) 4 (0–10)
Bone scan
N (%) of patients 975 (52.1) 447 (43.2) 313 (60.9) 134 (64.1) 81 (70.4) < .001
 Mean (SD) 0.75 (1.06) 0.50 (0.64) 0.88 (1.03) 1.13 (1.30) 1.81 (2.25) < .001
 Median (IQR) 1 (0–1) 0 (0–1) 1 (0–1) 1 (0–2) 1 (0–2)
CT scan
N (%) of patients 1,799 (96.0) 965 (93.2) 512 (99.6) 208 (99.5) 114 (99.1) .007
 Mean (SD) 4.82 (4.00) 3.10 (2.41) 6.07 (3.81) 7.40 (4.37) 10.10 (5.94) < .001
 Median (IQR) 4 (2–6) 2 (1–4) 5 (3–8) 6 (4–9) 9 (6–13)
MRI scan
N (%) of patients 590 (31.5) 244 (23.6) 189 (36.8) 94 (45.0) 63 (54.8) < .001
 Mean (SD) 0.54 (1.11) 0.35 (0.74) 0.62 (1.06) 0.91 (1.56) 1.29 (2.12) < .001
 Median (IQR) 0 (0–1) 0 (0–0) 0 (0–1) 0 (0–1) 1 (0–2)
PET-CT scan
N (%) of patients 414 (22.1) 105 (10.1) 157 (30.5) 88 (42.1) 64 (55.7) < .001
 Mean (SD) 0.46 (1.22) 0.12 (0.44) 0.56 (1.17) 0.94 (1.45) 2.10 (2.91) < .001
 Median (IQR) 0 (0–0) 0 (0–0) 0 (0–1) 0 (0–2) 1 (0–4)
Hospital admission
N (%) of patients 1,759 (93.9) 949 (91.7) 497 (96.7) 200 (95.7) 113 (98.3) .009
 Mean (SD) 3.14 (2.43) 2.52 (1.90) 3.61 (2.53) 4.12 (3.01) 4.83 (3.12) < .001
 Median (IQR) 3 (1–4) 2 (1–3) 3 (2–5) 4 (2–5) 4 (3–6)
Length of hospital stay, days
 Mean (SD) 9.6 (7.0) 10.9 (8.3) 8.7 (4.9) 7.6 (3.8) 7.1 (4.0) < .001
 Median (IQR) 8.0 (5.5–11.5) 8.4 (6.0–13.0) 7.5 (5.5–10.4) 6.7 (5.0–9.5) 6.0 (4.8–8.0)
Emergency department visit
N (%) of patients 1,690 (90.2) 923 (89.2) 461 (89.7) 195 (93.3) 111 (96.5) .009
 Mean (SD) 3.46 (3.22) 2.97 (2.63) 3.72 (3.37) 4.57 (4.49) 4.75 (3.60) < .001
 Median (IQR) 3 (1–5) 2 (1–4) 3 (2–5) 3 (2–6) 4 (2–7)
Intensive care unit visit
N (%) of patients 994 (53.1) 490 (47.3) 311 (60.5) 125 (59.8) 68 (59.1) .016
 Mean (SD) 0.88 (1.19) 0.74 (1.03) 1.05 (1.40) 1.00 (1.20) 1.07 (1.32) .004
 Median (IQR) 1 (0–1) 0 (0–1) 1 (0–2) 1 (0–1) 1 (0–2)
Office visit
N (%) of patients 1,873 (100.0) 1,035 (100.0) 514 (100.0) 209 (100.0) 115 (100.0) > .999
 Mean (SD) 30.5 (37.4) 13.8 (24.5) 41.4 (36.7) 57.2 (36.3) 84.7 (40.8) < .001
 Median (IQR) 18 (6–42) 7 (3–16) 32 (18–52) 47 (34–69) 75 (55–107)

Abbreviations. CT, computed tomography; HCRU, healthcare resource use; IQR, interquartile range; LOT, line of therapy; MRI, magnetic resonance imaging; PET-CT, positron emission tomography-computed tomography; SD, standard deviation.

Length of stay defined as total number of days hospitalized per patient across all hospital admissions.